首页 | 官方网站   微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   157623篇
  免费   13022篇
  国内免费   5344篇
医药卫生   175989篇
  2024年   473篇
  2023年   2119篇
  2022年   4485篇
  2021年   5981篇
  2020年   5248篇
  2019年   5120篇
  2018年   4935篇
  2017年   4879篇
  2016年   4993篇
  2015年   5056篇
  2014年   7873篇
  2013年   8931篇
  2012年   7481篇
  2011年   8620篇
  2010年   7502篇
  2009年   7335篇
  2008年   7387篇
  2007年   8500篇
  2006年   7827篇
  2005年   7869篇
  2004年   6891篇
  2003年   6174篇
  2002年   4526篇
  2001年   4511篇
  2000年   3654篇
  1999年   3407篇
  1998年   2408篇
  1997年   2127篇
  1996年   2231篇
  1995年   2156篇
  1994年   1884篇
  1993年   1707篇
  1992年   1474篇
  1991年   1279篇
  1990年   1069篇
  1989年   1013篇
  1988年   950篇
  1987年   729篇
  1986年   548篇
  1985年   618篇
  1984年   650篇
  1983年   404篇
  1982年   503篇
  1981年   427篇
  1980年   366篇
  1979年   306篇
  1978年   255篇
  1977年   207篇
  1976年   244篇
  1975年   151篇
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
91.
Medifoxamine, an antidepressant agent which has an original chemical structure, has been shown through in vitro studies, utilising radioligand binding in tissue homogenates, to bind with moderately high affinity to 5-HT1c and 5-HT2 receptor subtypes and to 5-HT uptake sites (IC50 950, 980, and 1,500 nM, respectively). It has been shown to bind in vivo to rat brain 5-HT2 receptors after acute treatment with high dose (50 mg/kg, i.e., 133.9 μmol/kg). After 14 days continuous treatment with low dose (20 mg/kg, 53.6 μmol/kg), a decrease in the capacity of [3H]-5-HT uptake and a dose-dependent down-regulation of 5-HT2 receptors in rat cerebral cortex were observed. These results indicate that medifoxamine, which has been shown previously to act through dopaminergic systems, interacts also with central serotonergic neurotransmission and particularly with the 5-HT2 receptors, which could contribute to its antidepressant effect.  相似文献   
92.
The known effects of drugs from a variety of pharmacologic/therapeutic classes on the respiratory system and worldwide regulatory requirements support the need for conducting respiratory evaluations in safety pharmacology. The objective of these studies is to evaluate the potential for drugs to cause secondary pharmacologic or toxicologic effects that influence respiratory function. Changes in respiratory function can result either from alterations in the pumping apparatus that controls the pattern of pulmonary ventilation or from changes in the mechanical properties of the lung that determine the transpulmonary pressures (work) required for lung inflation and deflation. Defects in the pumping apparatus are classified as hypo- or hyperventilation syndromes and are evaluated by examining ventilatory parameters in a conscious animal model. The ventilatory parameters include respiratory rate, tidal volume, minute volume, peak (or mean) inspiratory flow, peak (or mean) expiratory flow, and fractional inspiratory time. Defects in mechanical properties of the lung are classified as obstructive or restrictive disorders and can be evaluated in animal models by performing flow-volume and pressure-volume maneuvers, respectively. The parameters used to detect airway obstruction include peak expiratory flow, forced expiratory flow at 25 and 75% of forced vital capacity, and a timed forced expiratory volume, while the parameters used to detect lung restriction include total lung capacity, inspiratory capacity, functional residual capacity, and compliance. Measurement of dynamic lung resistance and compliance, obtained continuously during tidal breathing, is an alternative method for evaluating obstructive and restrictive disorders, respectively, and is used when the response to drug treatment is expected to be immediate (within minutes post-dose). The species used in the safety pharmacology studies conducted in our laboratory are the same as those used in toxicology studies since pharmacokinetic and toxicologic/pathologic data are available in these species. These data can be used to help select test measurement intervals and doses and to aid in the interpretation of functional change. The techniques and procedures for measuring respiratory function parameters are well established in guinea pigs, rats, and dogs.  相似文献   
93.
Modafinil is a new drug used in the treatment of narcolepsy. Its administration in mice induced a dose-dependent increase in locomotor activity. The effects of modafinil were compared with those of dexamphetamine on three tests that assessed the anxiety level (drugs were used at doses which induced a roughly similar stimulation of locomotor activity). Dexamphetamine increased the latency of exploration of a white compartment, increased thigmotaxis in an open-field and decreased the time spent in the open arms of an elevated plus-maze. None of these responses was significantly modified by modafinil. We conclude that modafinil does not share the anxiogenic effects of dexamphetamine.  相似文献   
94.
上海市少年儿童住院医疗保险费用分析   总被引:1,自引:0,他引:1  
本文研究了上海市少年儿童住院医疗保险的费用水平、特点和影响因素。研究结果表明:手术与否、患者年龄、就诊地点、家长医疗保健制度和医院等级的差异造成次均费用的差异;次均费用构成比较合理,药品费比例低于全市水平。病种费用居前三位的是白血病、肺炎和先天性心脏病;特殊病种占总医疗服务人次的4.90%,而医疗费用占总费用的32.57%。  相似文献   
95.
医院综合效益评价案例分析   总被引:2,自引:0,他引:2  
运用层次分析法建立了医院综合效益评价指标体系,开发了医院综合效益九型评价图,用于显著评价结果。在此基础上进行了3个案例的评价分析。论述了通过对西南地区27所医院综合效益4年多的追踪分析所发现的共性问题,并提出了相应的管理对策。  相似文献   
96.
五所医院特需医疗服务状况调查   总被引:1,自引:1,他引:0  
通过对上海医科大学附属华山医院、协和医院、北京同仁医院、中山医科大学附属第一医院、浙江医科大学附属第二医院开展的特需医疗服务情况的调查,论述了五所医院的具体做法,在对调查结果进行分析的基础上,就特需医疗服务的管理提出了建议。  相似文献   
97.
系统地介绍了军队卫生系统计算机应用的概况,总结了军队卫生系统自动化建设的主要经验,并提出了加强军队卫生系统计算机应用的设想。  相似文献   
98.
Non-ionic contrast media (CM) are proven to be significantly safer than the high osmolar ionic contrast media (HOCM). Nevertheless deaths are reported after administration of non-ionic agents. The aim of the study was to investigate the rate of adverse reactions to non-ionic CM with special regard to high-risk patients and the effects of premedication with H1-and H2-receptor antagonists.In a prospective study conducted over about 2 years 12 995 examinations with intravenous or intra-arterial non-ionic CM were evaluated. Premedication with H1-and H2-antagonists was used in 1276 high-risk patients with known adverse reaction to CM, history of allergy or severe cardiac or pulmonary disease. 229 patients received no premedication inspite of known risk factors. In total, there were 143 (1.10%) adverse reactions (mild in 0.58%, moderate in 0.41% and severe in 0.05%). In high-risk patients there were adverse reactions in 4.37% without and in 1.57% with premedication. There were no severe adverse reactions in the high-risk patients after premedication. The age of the patient, CM dosage and CM concentration were not shown to be risk factors in the present study. In conclusion, the additional premedication with H1- and H2-antagonists could be an effective agent to reduce the risk of mild and moderate adverse reactions and to avoid severe adverse reactions in high-risk patients. Correspondence to: U. Fink  相似文献   
99.
Omeprazole is a substituted benzimidazole that causes dose-dependent intracellular inhibition of gastric acid secretion in humans. This double-blind study examined the effect of omeprazole in decreasing gastric acidity and gastric residual volume in outpatient adults. Unpremedicated outpatients, ASA I-III, 18 years or older (n = 17), were randomly assigned to receive omeprazole 80 mg, or placebo by mouth the night before scheduled elective outpatient surgery. The patients were fasted for 8 h prior to surgery. After the patient was anesthetized, an orogastric tube was inserted with proper placement verified by auscultation for gastric sounds. Gastric residual contents were withdrawn into a Luken's trap, and pH was then determined and gastric volume indexed to weight (ml.kg-1). Data were analyzed by a t-test, with P less than 0.05 considered statistically significant. Patient characteristics of both groups were similar. There was a statistically significant difference between the two groups for pH (P = 0.02), but not between the two groups for gastric volume indexed to weight (P = 0.07).  相似文献   
100.
443例(男225例,女218例;年龄36±14a)皮肤病患者,其中150例(扁平疣52例、寻常疣55例、银屑病43例)外用含1.8%十二烷氮(艹卓)酮的1%氟尿嘧啶(5-FU)凝胶作为治疗组,148例外用1%5-FU凝胶及145例外用2.5%5-FU霜作为2个对照组。经双盲对照临床试验,结果表明含1.8%十二烷氮(艹卓)酮的1%5-FU凝胶的疗效明显优于2个对照组(P<0.01及P<0.005)。证明氮(艹卓)酮对5-FU确有渗透促进作用。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号